Preventive Treatment of Migraine
- 1 April 1997
- journal article
- review article
- Published by SAGE Publications in Cephalalgia
- Vol. 17 (2) , 67-72
- https://doi.org/10.1046/j.1468-2982.1997.1702067.x
Abstract
The pharmacologic treatment of migraine may be acute (abortive, symptomatic) or preventive (prophylactic). Most migraine preventive medications were designed to treat other disorders (e.g., propranolol for hypertension, valproate for epilepsy, etc.). Preventive medication is usually given daily for months or years; however, treatment can be episodic, subacute, or chronic. The medications can be divided into two major categories: (i) Alternatives of high efficacy, which include β- blockers, tricyclic antidepressants, and divalproex, and of lower efficacy, which include selective serotonin reuptake inhibitors, calcium channel antagonists, and non-steroidal antiinflammatory drugs and (ii) second-line choices of high efficacy, which include methysergide and monoamine oxidase inhibitors. The choice of preventive treatment depends on the individual drug's efficacy and side effects, the patient's wants, needs, and response to prior treatment, and the presence of any comorbid or coexistent disease. Most patients require acute headache treatment. Some require preventive treatment. Patients on preventive medication still require acute treatment for breakthrough attacks. Many patients find that their acute attacks are more manageable if they are on a preventive medication. The choice of preventive treatment depends on the individual drug's efficacy and side effects, the patient's wants, needs, and response to prior treatment, and the presence of any comorbid or coexistent disease.Keywords
This publication has 21 references indexed in Scilit:
- Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4Cell, 1996
- The serotonin (5-HT) antagonist methysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the ratBrain Research, 1995
- Serotonin (5‐HT) and MigraineHeadache: The Journal of Head and Face Pain, 1994
- Headache and Cortisol Responses to M-Chlorophenylpiperazine are Highly CorrelatedCephalalgia, 1993
- Prevalence of Migraine Headache in the United StatesJAMA, 1992
- Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends in Pharmacological Sciences, 1992
- Developments in 5-Hydroxytriptamine Receptor Pharmacology in MigraineNeurologic Clinics, 1990
- Anti‐Migraine Drugs in Development: Advances in Serotonin Receptor PharmacologyHeadache: The Journal of Head and Face Pain, 1990
- Contingent Negative Variation and Efficacy of Beta-Blocking Agents in MigraineCephalalgia, 1986
- MethysergidePublished by S. Karger AG ,1967